revolutionized CML therapy
CML cases
CML therapeutic course
survival of patients
resistant patients
therapeutic response of patients
LeukoPredict
beginning of Imatinib therapy
aggressive blood cancer
therapy initiation
life-threatening cancer
resistance
introduction of Imatinib
Chronic Myelogenous Leukemia
personalized therapeutic alternative
Bcr-Abl potent inhibitor
cure of Chronic Myeloid Leukemia
healthcare system
active protein
tumorigenic capability
clinicians
costs
year
gold standard
drugs
controllable disease
Europe
occurrence
maximal efficacy
cells
diagnostic kit
long run
USA
test